side effects to glp-1 GI Adverse of Glucagon-Like Peptide-1 Receptor Agonists Glucagon-like Receptor-1 agonists for obesity:

Restrained eating is a tendency to deliberately and consciously restrict food intake to control body weight, despite feelings of hunger

54% of patients achieved more than 15% weight loss compared to 6% on placebo

Weight-loss conversations have taken a dramatic turn ever since medications like Ozempic, Mounjaro and other GLP-1 based drugs entered the spotlight

Most early erection changes during fast weight loss are temporary and tied to an aggressive calorie deficit, not permanent damage from the medication

Men typically see the best results from CJC-1295 when they: Have early or mild low-T symptoms but are not yet in the clinical hypogonadal range Want better recovery and athletic performance Are focused on long-term wellness and healthy aging Want to improve sleep quality and energy without starting TRT Want to support natural GH production that declines with age (GH decreases approximately 14 percent per decade after age 30) Are already on TRT and want additional metabolic and recovery benefits Who May Not Be a Good Candidate CJC-1295 may not be appropriate for: Men with severely low testosterone (below 200 ng/dL) who need direct testosterone therapy People with active cancer or a history of hormone-sensitive cancers People with uncontrolled diabetes or pituitary disorders Anyone pregnant or breastfeeding Anyone self-administering without medical supervision How Long Does CJC-1295 Take to Work